ABILIFY MAINTENA 960 mg, suspension injectable à libération prolongée en seringue préremplie
Аналоги ABILIFY MAINTENA 960 mg, suspension injectable à libération prolongée en seringue préremplie
Знайдіть доступніші аналоги та дженерики для ABILIFY MAINTENA 960 mg, suspension injectable à libération prolongée en seringue préremplie.
Активний інгредієнт: ARIPIPRAZOLE
Опис товару
About ABILIFY MAINTENA
ABILIFY MAINTENA is a medication containing the active ingredient Aripiprazole, classified as Atypical Antipsychotic. Aripiprazole, sold under the brand name Abilify, among others, is a unique atypical antipsychotic primarily used in the treatment of schizophrenia, mania in bipolar disorder, and irritability associated with autism spectrum disorder; other uses include as an add-on treatment for major depressive disorder.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Aripiprazole is indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment.
- Used for: The oral formulations are indicated for: • Schizophrenia (14
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Aripiprazole, the active ingredient in ABILIFY MAINTENA, belongs to the Atypical Antipsychotic class. 1 INDICATIONS AND USAGE Aripiprazole is indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia (14. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking ABILIFY MAINTENA. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use ABILIFY MAINTENA for extended periods without medical advice.
Знайти в аптеках
Порівняйте місцеві ціни та відстань для ABILIFY MAINTENA 960 mg, suspension injectable à libération prolongée en seringue préremplie.
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.